CSEM announces the creation of a new startup, aktiia SA, which has been launched to commercialize its proprietary cuffless optical Blood Pressure Monitoring technology (oBPMTM).
The Biggest Epidemic Ever Known to Mankind
According to the World Health Organization, every one out of three adults suffers from hypertension – that is 1.5 billion adults worldwide. Hypertension can lead to severe complications, such as stroke and heart failure. Each year, this illness results in 7.5 million premature deaths worldwide. The paradox of hypertension is that most people suffering from this condition are unaware of it. As such, hypertension is known as the “silent killer”. Furthermore, the current «gold standard» for blood pressure measurement is performed with a cuff placed around the arm. This 110 years old technology is cumbersome and leads to low compliance for patients prescribed to self-monitor. As a consequence, healthcare professionals lack access to complete and high-quality data for their diagnosis and the treatment of this disease.
Facing Hypertension with a Strong Team and a Proven Track Record
Awarded the Neode Prize 2017, Josep Solà and Mattia Bertschi, together with their team at CSEM, developed the revolutionary cuffless optical Blood Pressure Monitoring technology (oBPM™). oBPM™ combines common optical sensors and clinically validated software algorithms to measure an individual’s blood pressure at the wrist. aktiia builds on a strong patent portfolio, over 15 years of CSEM experience in the field of non-occlusive blood pressure monitoring, more than 30 peer-reviewed publications, clinical trials in acute and low-acute settings, and worldwide acknowledgement of its accuracy. In the past months, the co-Founders of the company, Mattia Bertschi (CEO) and Josep Sola (CTO) have built up, together with Tobias Pforr (Chief Marketing Officer), a strong management team supported by leading US and Swiss venture capital investors. In the coming months, aktiia will be building a global team with offices in Switzerland and the US and expand its global strategic partnership network in Europe and the US.
Launch of the First Accurate Blood Pressure Monitor Solely Based on Optical Measurements
In the coming months, aktiia will release its technology in form of a CE-certified and FDA-approved medical wrist wearable that will seamlessly integrate into people’s lives. Having robust and detailed yet comfortable monitoring of one’s blood pressure will allow patients and healthcare professionals alike to better understand the underlying causes of high blood pressure in order to develop new approaches to deal with this limiting and life-threatening condition.